Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1999-7-15
pubmed:abstractText
CD23, also known as the low affinity IgE receptor (FcepsilonRII), has been hypothesized to have a role in IgE regulation. A new CD23 transgenic mouse was generated using the MHC class I promoter and IgH enhancer to further test the hypothesis that CD23 plays a role in the down-regulation of IgE. Study of three founder lines by FACS showed overexpression to varying extents on both B and T lymphocytes. No alterations in lymphocyte populations was observed. All three founder lines exhibited strong suppression of IgE in response to DNP-keyhole limpet hemocyanin/alum and Nippostrongylus brasiliensis infection compared with that in parental or littermate controls. The founder line exhibiting the highest level of suppression also was less susceptible to Ag-induced systemic anaphylactic shock. Overall, the data support the concept that enhancing CD23 levels can be used to suppress IgE-mediated disease. The mechanism involves decreased IgE synthesis, because the serum half-life of IgE was not altered in transgenics, and enzyme-linked immunospot analysis demonstrated lower IgE-producing cells stimulated by injection of anti-IgD. Transgenics also exhibited significantly decreased IgG1 responses and exhibited lower levels of all Ig isotypes, although this was more variable in different founder lines.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
163
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
217-23
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10384119-Alum Compounds, pubmed-meshheading:10384119-Anaphylaxis, pubmed-meshheading:10384119-Animals, pubmed-meshheading:10384119-Antibodies, Anti-Idiotypic, pubmed-meshheading:10384119-Antibodies, Helminth, pubmed-meshheading:10384119-Half-Life, pubmed-meshheading:10384119-Haptens, pubmed-meshheading:10384119-Hemocyanin, pubmed-meshheading:10384119-Immune Tolerance, pubmed-meshheading:10384119-Immunoglobulin E, pubmed-meshheading:10384119-Immunoglobulins, pubmed-meshheading:10384119-Immunophenotyping, pubmed-meshheading:10384119-Injections, Intravenous, pubmed-meshheading:10384119-Injections, Subcutaneous, pubmed-meshheading:10384119-Male, pubmed-meshheading:10384119-Mice, pubmed-meshheading:10384119-Mice, Inbred BALB C, pubmed-meshheading:10384119-Mice, Inbred C57BL, pubmed-meshheading:10384119-Mice, Transgenic, pubmed-meshheading:10384119-Nippostrongylus, pubmed-meshheading:10384119-Receptors, IgE, pubmed-meshheading:10384119-Strongylida Infections
pubmed:year
1999
pubmed:articleTitle
Humoral response suppression observed with CD23 transgenics.
pubmed:affiliation
Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond 23298, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.